Literature DB >> 34394224

Sensitizing multi drug resistant Staphylococcus aureus isolated from surgical site infections to antimicrobials by efflux pump inhibitors.

Amr A Baiomy1, Ghada H Shaker1, Hisham A Abbas1.   

Abstract

BACKGROUND: Staphylococcus aureus is a common hospital acquired infections pathogen. Multidrug-resistant Methicillin-resistant Staphylococcus aureus represents a major problem in Egyptian hospitals. The over-expression of efflux pumps is a main cause of multidrug resistance. The discovery of efflux pump inhibitors may help fight multidrug resistance by sensitizing bacteria to antibiotics. This study aimed to investigate the role of efflux pumps in multidrug resistance.
METHODS: Twenty multidrug resistant S. aureus isolates were selected. Efflux pumps were screened by ethidium bromide agar cartwheel method and polymerase chain reaction. The efflux pump inhibition by seven agents was tested by ethidium bromide agar cartwheel method and the effect on sensitivity to selected antimicrobials was investigated by broth microdilution method.
RESULTS: Seventy percent of isolates showed strong efflux activity, while 30% showed intermediate activity. The efflux genes mdeA, norB, norC, norA and sepA were found to play the major role in efflux, while genes mepA, smr and qacA/B had a minor role. Verapamil and metformin showed significant efflux inhibition and increased the sensitivity to tested antimicrobials, while vildagliptin, atorvastatin, domperidone, mebeverine and nifuroxazide showed no effect.
CONCLUSION: Efflux pumps are involved in multidrug resistance in Staphylococcus aureus. Efflux pump inhibitors could increase the sensitivity to antimicrobials.
© 2020 Ahmed BA et al.

Entities:  

Keywords:  Staphylococcus aureus; efflux pump inhibitors; multidrug resistance

Mesh:

Substances:

Year:  2020        PMID: 34394224      PMCID: PMC8351819          DOI: 10.4314/ahs.v20i4.16

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  23 in total

1.  Susceptibility of 169 USA300 methicillin-resistant Staphylococcus aureus isolates to two copper-based biocides, CuAL42 and CuWB50.

Authors:  Vicki Ann Luna; Tony J Hall; Debbie S King; Andrew C Cannons
Journal:  J Antimicrob Chemother       Date:  2010-03-25       Impact factor: 5.790

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

3.  Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus.

Authors:  Saulo R Tintino; Cícera D M Oliveira-Tintino; Fábia F Campina; Raimundo L P Silva; Maria do S Costa; Irwin R A Menezes; João T Calixto-Júnior; José P Siqueira-Junior; Henrique D M Coutinho; Tereza C Leal-Balbino; Valdir Q Balbino
Journal:  Microb Pathog       Date:  2016-04-04       Impact factor: 3.738

4.  Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009.

Authors:  Jean Longtin; Christine Seah; Krystal Siebert; Allison McGeer; Andrew Simor; Yves Longtin; Donald E Low; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

5.  Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.

Authors:  Hyung Gyun Kim; Tran Thi Hien; Eun Hee Han; Yong Pil Hwang; Jae Ho Choi; Keon Wook Kang; Kwang-il Kwon; Bong-Hee Kim; Sang Kyum Kim; Gye Yong Song; Tae Cheon Jeong; Hye Gwang Jeong
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

6.  Cloning and sequencing of the ompA gene of Enterobacter sakazakii and development of an ompA-targeted PCR for rapid detection of Enterobacter sakazakii in infant formula.

Authors:  Manoj Kumar Mohan Nair; Kumar S Venkitanarayanan
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility.

Authors:  Wang-Huei Sheng; Jann-Tay Wang; Tsai-Ling Lauderdale; Chia-Ming Weng; Duckling Chen; Shan-Chwen Chang
Journal:  Diagn Microbiol Infect Dis       Date:  2009-03       Impact factor: 2.803

8.  Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.

Authors:  Naiem Ahmad Wani; Samsher Singh; Saleem Farooq; Sudha Shankar; Surrinder Koul; Inshad Ali Khan; Rajkishor Rai
Journal:  Bioorg Med Chem Lett       Date:  2016-07-27       Impact factor: 2.823

Review 9.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Resistance to Antimicrobials Mediated by Efflux Pumps in Staphylococcus aureus.

Authors:  Sofia S Costa; Elisabete Junqueira; Cláudia Palma; Miguel Viveiros; José Melo-Cristino; Leonard Amaral; Isabel Couto
Journal:  Antibiotics (Basel)       Date:  2013-03-13
View more
  2 in total

Review 1.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

2.  Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus.

Authors:  Safaa Abdel-Aal Mohamed Abdel-Karim; Amira Mohamed Ali El-Ganiny; Mona Abdelmonem El-Sayed; Hisham Abdelmonem Abdelhamid Abbas
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.